参考文献/References:
[1] Shergalis A, Bankhead A 3rd, Luesakul U, et al. Current
challenges and opportunities in treating glioblastoma [J].
Pharmacol Rev, 2018, 70: 412-445.
[2] Lefranc F, Le Rhun E, Kiss R, et al. Glioblastoma quo
vadis: will migration and invasiveness reemerge as thera-
peutic targets [J]? Cancer Treat Rev, 2018, 68: 145-154.
[3] Gallego O. Nonsurgical treatment of recurrent glioblastoma
[J]. Curr Oncol, 2015, 22: e273-281.
[4] Grigoriadis A, Mackay A, Reis-Filho JS, et al. Establish-
ment of the epithelial-specific transcriptome of normal and
malignant human breast cells based on MPSS and array
expression data [J]. Breast Cancer Res, 2006, 8: R56.
[5] Li S, Liu X, Liu T, et al. Identification of biomarkers corre-
lated with the TNM staging and overall survival of patients
with bladder cancer [J]. Front Physiol, 2017, 8: 947.
[6] Cheon DJ, Tong Y, Sim MS, et al. A collagen-remodeling
gene signature regulated by TGF-beta signaling is associa-
ted with metastasis and poor survival in serous ovarian
cancer [J]. Clin Cancer Res, 2014, 20: 711-723.
[7] Vakilian A, Khorramdelazad H, Heidari P, et al. CCL2/
CCR2 signaling pathway in glioblastoma multiforme [J].
Neurochem Int, 2017, 103: 1-7.
[8] Bonavia R, Inda MM, Cavenee WK, et al. Heterogeneity
maintenance in glioblastoma: a social network [J]. Cancer
Res, 2011, 71: 4055-4060.
[9] Ohno I, Hashimoto J, Shimizu K, et al. A cDNA cloning of
human AEBP1 from primary cultured osteoblasts and its
expression in a differentiating osteoblastic cell line [J].
Biochem Biophys Res Commun, 1996, 228: 411-414.
[10] Kim SW, Muise AM, Lyons PJ, et al. Regulation of adipoge-
nesis by a transcriptional repressor that modulates MAPK
activation [J]. J Biol Chem, 2001, 276: 10199-10206.
[11] Lou Y, Chen YD, Sun FR, et al. Potential regulators driving
the transition in nonalcoholic fatty liver disease: a stage-
based view [J]. Cell Physiol Biochem, 2017, 41: 239-251.
[12] Tamura T, Ichikawa T, Nakahata S, et al. Loss of NDRG2
expression confers oral squamous cell carcinoma with
enhanced metastatic potential [J]. Cancer Res, 2017, 77:
2363-2374.
[13] Yang H, Huang S, Wei Y, et al. Curcumin enhances the
anticancer effect of 5-fluorouracil against gastric cancer
through down-regulation of COX-2 and NF- kappa B
signaling pathways [J]. J Cancer, 2017, 8: 3697-3706.
[14] Ekambaram P, Lee JL, Hubel NE, et al. The CARMA3-
Bcl10-MALT1 signalosome drives NF kappa B activation
and promotes aggressiveness in angiotensin II receptor-
positive breast cancer [J]. Cancer Res, 2018, 78: 1225-
1240.
[15] Li J, Lau GK, Chen L, et al. Interleukin 17A promotes hepa-
tocellular carcinoma metastasis via NF-kB induced matrix
metalloproteinases 2 and 9 expression [J]. PLoS One, 2011,
6: e21816.
[16] Bie L, Zhao G, Cheng P, et al. The accuracy of survival time
prediction for patients with glioma is improved by measur-
ing mitotic spindle checkpoint gene expression [J]. PLoS
One, 2011, 6: e25631.
相似文献/References:
[1]谢宝树 张 林 王 宇 贾 锋 殷玉华.复发性多发胶质母细胞瘤的预后分析[J].中国临床神经外科杂志,2016,(06):333.[doi:10.13798/j.issn.1009-153X.2016.06.005]
XIE Bao-shu,ZHANG Lin,WANG Yu,et al.Analysis of prognoses in patients with recurrent multiple glioblastomas[J].,2016,(08):333.[doi:10.13798/j.issn.1009-153X.2016.06.005]
[2]宋贵东 综述 高之宪 审校.贝伐单抗治疗复发胶质母细胞瘤的研究进展[J].中国临床神经外科杂志,2015,(10):638.[doi:10.13798/j.issn.1009-153X.2015.10.022]
[3]李继强 杨吉安 邵灵敏 吴庭枫 刘宝辉 陈谦学.稳定低表达BAG3的胶质母细胞瘤U87细胞株的构建及鉴定[J].中国临床神经外科杂志,2015,(06):353.[doi:10.13798/j.issn.1009-153X.2015.06.011]
LI Ji-qiang,YANG Ji-an,SHAO Ling-min,et al.Construction and identification of U87 glioblastoma cell strain with a stable low expression of BAG3[J].,2015,(08):353.[doi:10.13798/j.issn.1009-153X.2015.06.011]
[4]桂志勇 冯 军 黄俊红 白敬洋.靶向沉默c-fos基因表达对胶质瘤U87MG细胞增殖与侵袭的影响[J].中国临床神经外科杂志,2017,(12):834.[doi:10.13798/j.issn.1009-153X.2017.12.011]
GUI Zhi-yong,FENG Jun,HUANG Jun-hong,et al.Effects of c-fos targeted silence on proliferation and invasiveness of human glioma cell U87[J].,2017,(08):834.[doi:10.13798/j.issn.1009-153X.2017.12.011]
[5]王娇燕 孟凡华 刘魏然 魏春晓 林丽萍.SWI在胶质母细胞瘤与单发脑转移瘤鉴别中的价值[J].中国临床神经外科杂志,2018,(01):13.[doi:10.13798/j.issn.1009-153X.2018.01.005]
WANG Jiao-yan,MENG Fan-hua,LIU Wei-ran,et al.Value of susceptibility-weighted imaging in differentiative diagnosis of glioblastomas and solitary brain metastases[J].,2018,(08):13.[doi:10.13798/j.issn.1009-153X.2018.01.005]
[6]张治元 王汉东 樊友武 贾 玥 吴晋蓉.胶质肉瘤15例分析及文献复习[J].中国临床神经外科杂志,2018,(02):69.
ZHANG Zhi-yuan,WANG Han-dong,FAN You-wu,et al.Diagnosis and treatment of gliosarcoma: a report of 15 cases and literature review[J].,2018,(08):69.
[7]郑锐哲 姜秀峰 陈二涛 孙兆良 冯东福.胶质母细胞瘤卒中术后继发硬膜下水瘤1例[J].中国临床神经外科杂志,2019,(02):128.[doi:10.13798/j.issn.1009-153X.2019.02.022]
[8]胡 玥,薛小燕,李子超,等.阿苯达唑抑制胶质瘤裸鼠模型肿瘤生长[J].中国临床神经外科杂志,2019,(06):348.[doi:10.13798/j.issn.1009-153X.2019.06.010]
HU Yue,XUE Xiao-yan,LI Zi-chao,et al.Albendazole inhibits tumor growth in nude mice model of glioma[J].,2019,(08):348.[doi:10.13798/j.issn.1009-153X.2019.06.010]
[9]殷安安 陆 南 贺亚龙 章 翔 刘玉河.TRIM38基因非CpG岛DNA甲基化与胶质母细胞瘤临床预后的关系[J].中国临床神经外科杂志,2020,(02):76.[doi:10.13798/j.issn.1009-153X.2020.02.005]
YIN An-an,LU Nan,HE Ya-long,et al.Impacts of TRIM38 non-CpG island DNA methylation alterations on clinical prognosis in patients with glioblastomas[J].,2020,(08):76.[doi:10.13798/j.issn.1009-153X.2020.02.005]
[10]吴 蛟 易 勇 赵卓琳 周良学 周世军.贝伐珠单抗联合化疗治疗胶质母细胞瘤的meta分析[J].中国临床神经外科杂志,2020,(02):82.[doi:10.13798/j.issn.1009-153X.2020.02.007]
WU Jiao,YI Yong,ZHAO Zhuo-lin,et al.Efficacy and safety of bevacizumab combined with chemotherapy for glioblastoma: a meta-analysis[J].,2020,(08):82.[doi:10.13798/j.issn.1009-153X.2020.02.007]